Renal function to 5 years after late conversion of kidney transplant patients to everolimus: a randomized trial
BackgroundFew trials have investigated late preemptive conversion of kidney transplant patients from a calcineurin inhibitor (CNI) to an mTOR inhibitor.MethodsIn an open-label, 12-month, prospective, randomized, parallel-group study, maintenance kidney transplant patients (>6 months post-transpla...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2015
|
| In: |
Journal of nephrology
Year: 2014, Jahrgang: 28, Heft: 1, Pages: 115-123 |
| ISSN: | 1724-6059 |
| DOI: | 10.1007/s40620-014-0134-4 |
| Online-Zugang: | Verlag, Volltext: http://dx.doi.org/10.1007/s40620-014-0134-4 Verlag, Volltext: https://link.springer.com/article/10.1007/s40620-014-0134-4 
|
| Verfasserangaben: | Klemens Budde, Claudia Sommerer, Thomas Rath, Petra Reinke, Hermann Haller, Oliver Witzke, Barbara Suwelack, Daniel Baeumer, Christian Sieder, Martina Porstner, Wolfgang Arns |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 156054970X | ||
| 003 | DE-627 | ||
| 005 | 20230428071330.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 170706r20152014xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40620-014-0134-4 |2 doi | |
| 035 | |a (DE-627)156054970X | ||
| 035 | |a (DE-576)490549705 | ||
| 035 | |a (DE-599)BSZ490549705 | ||
| 035 | |a (OCoLC)1340976761 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Budde, Klemens |e VerfasserIn |0 (DE-588)1111064571 |0 (DE-627)865478902 |0 (DE-576)475913329 |4 aut | |
| 245 | 1 | 0 | |a Renal function to 5 years after late conversion of kidney transplant patients to everolimus |b a randomized trial |c Klemens Budde, Claudia Sommerer, Thomas Rath, Petra Reinke, Hermann Haller, Oliver Witzke, Barbara Suwelack, Daniel Baeumer, Christian Sieder, Martina Porstner, Wolfgang Arns |
| 264 | 1 | |c 2015 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online: 06 September 2014 | ||
| 500 | |a Gesehen am 06.07.2017 | ||
| 520 | |a BackgroundFew trials have investigated late preemptive conversion of kidney transplant patients from a calcineurin inhibitor (CNI) to an mTOR inhibitor.MethodsIn an open-label, 12-month, prospective, randomized, parallel-group study, maintenance kidney transplant patients (>6 months post-transplant) either switched from CNI to everolimus or continued their current CNI regimen. Patients who completed the core study were followed to 5 years post-randomization.ResultsOf 93 randomized patients, 78 completed the core study and 67 attended the final 60-month study visit. Mean time post-transplant at baseline was 82.6 months and 70.5 months in the everolimus and CNI groups, respectively. At month 60, adjusted mean eGFR (Nankivell) was 63.0 (95 % CI 57.8, 68.2) mL/min/1.73 m2 in the everolimus group versus 57.9 (95 % CI 52.6, 63.1) mL/min/1.73 m2 in the CNI group, a difference of 5.1 (95 % CI −0.6, 10.8) mL/min/1.73 m2 (p = 0.076). Among patients who remained on randomized study drug at month 60, mean eGFR (Nankivell) was 71.6 (95 % CI 64.2, 79.0) mL/min/1.73 m2 in everolimus-treated patients (n = 21) versus 60.6 (95 % CI 55.1, 66.1) mL/min/1.73 m2 in CNI-treated patients (n = 29) (mean difference 11.0; 95 % CI 3.6, 18.5 mL/min/1.73 m2; p = 0.005). No cases of BPAR occurred from randomization to month 60 in either group. Graft loss occurred in three everolimus-treated patients and one CNI-treated patient. No unexpected safety concerns were observed in either group.ConclusionLate preemptive conversion of maintenance kidney transplant patients from CNI to everolimus may be associated with improved long-term renal function and preserves immunosuppressive efficacy. Patient numbers were low, but these findings merit further investigation. | ||
| 534 | |c 2014 | ||
| 700 | 1 | |a Sommerer, Claudia |d 1971- |e VerfasserIn |0 (DE-588)121857654 |0 (DE-627)705680002 |0 (DE-576)292921829 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of nephrology |d Milano : Springer, 1996 |g 28(2015), 1, Seite 115-123 |h Online-Ressource |w (DE-627)269534512 |w (DE-600)1475007-7 |w (DE-576)100800513 |x 1724-6059 |7 nnas |a Renal function to 5 years after late conversion of kidney transplant patients to everolimus a randomized trial |
| 773 | 1 | 8 | |g volume:28 |g year:2015 |g number:1 |g pages:115-123 |g extent:9 |a Renal function to 5 years after late conversion of kidney transplant patients to everolimus a randomized trial |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s40620-014-0134-4 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://link.springer.com/article/10.1007/s40620-014-0134-4 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20170706 | ||
| 993 | |a Article | ||
| 994 | |a 2015 | ||
| 998 | |g 121857654 |a Sommerer, Claudia |m 121857654:Sommerer, Claudia |d 50000 |e 50000PS121857654 |k 0/50000/ |p 2 | ||
| 999 | |a KXP-PPN156054970X |e 2973279178 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"note":["Published online: 06 September 2014","Gesehen am 06.07.2017"],"origin":[{"dateIssuedKey":"2015","dateIssuedDisp":"2015"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"title":[{"title":"Renal function to 5 years after late conversion of kidney transplant patients to everolimus","title_sort":"Renal function to 5 years after late conversion of kidney transplant patients to everolimus","subtitle":"a randomized trial"}],"language":["eng"],"person":[{"family":"Budde","display":"Budde, Klemens","role":"aut","given":"Klemens"},{"role":"aut","given":"Claudia","display":"Sommerer, Claudia","family":"Sommerer"}],"relHost":[{"recId":"269534512","pubHistory":["Nachgewiesen 9.1996 -"],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["Società Italiana Nefrologia"]},"id":{"zdb":["1475007-7"],"eki":["269534512"],"issn":["1724-6059"]},"disp":"Renal function to 5 years after late conversion of kidney transplant patients to everolimus a randomized trialJournal of nephrology","corporate":[{"display":"Società Italiana di Nefrologia","role":"isb"}],"language":["eng"],"part":{"issue":"1","extent":"9","volume":"28","year":"2015","pages":"115-123","text":"28(2015), 1, Seite 115-123"},"title":[{"title_sort":"Journal of nephrology","subtitle":"JN","title":"Journal of nephrology"}],"note":["Gesehen am 14.02.2025","Fortsetzung der Druck-Ausgabe"],"origin":[{"publisherPlace":"Milano ; Milano","dateIssuedDisp":"1996-","dateIssuedKey":"1996","publisher":"Springer ; Wichtig"}],"titleAlt":[{"title":"JN"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"id":{"doi":["10.1007/s40620-014-0134-4"],"eki":["156054970X"]},"name":{"displayForm":["Klemens Budde, Claudia Sommerer, Thomas Rath, Petra Reinke, Hermann Haller, Oliver Witzke, Barbara Suwelack, Daniel Baeumer, Christian Sieder, Martina Porstner, Wolfgang Arns"]},"physDesc":[{"extent":"9 S."}],"recId":"156054970X"} | ||
| SRT | |a BUDDEKLEMERENALFUNCT2015 | ||